Typical carcinoid arising in mature teratoma of anterior mediastinum

Department of Pathology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.
Asian cardiovascular & thoracic annals 02/2012; 20(1):80-2. DOI: 10.1177/0218492311428185
Source: PubMed


Teratoma is the second most common mediastinal neoplasm, but malignant transformation in mature teratomas is uncommon at both gonadal and extragonadal sites. A 35-year-old woman presented with an anterior mediastinal mass. Computed tomography suggested a teratoma. Meticulous pathological examination helped in detecting a neuroendocrine neoplasm (carcinoid) within the mature teratoma. Malignant transformation in a teratoma is difficult to diagnose on clinical and radiological assessment; histopathology is essential to detect the malignant nature of these neoplasms.

Download full-text


Available from: Niraj Kumari, Sep 24, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background. A carcinoid arising from a mature cystic teratoma of the mediastinum is rare. Case. A 38-year-old man was admitted to our hospital for evaluation of an abnormal shadow on a chest radiograph. Chest CT scan and MRI showed a well-defined mass with calcification and heterogeneous components in the right anterior mediastinum. Video-assisted thoracic surgery was performed to resect the tumor, which was suspected to be a mediastinal teratoma. The histopathological diagnosis was a carcinoid arising from a mature cystic teratoma of the mediastinum. Conclusion. We report a rare case of a carcinoid arising from a mature cystic teratoma of the mediastinum.
    No preview · Article · Dec 2012 · Haigan
  • [Show abstract] [Hide abstract]
    ABSTRACT: Platinum (Pt)-based chemotherapy is an important regimen in the clinical treatment of cancer, but development of drug resistance presents a major challenge. One key mechanism involved in resistance to Pt drugs is the decrease of intracellular Pt due to the drug efflux through the glutathione (GSH)-mediated export, and this is particularly significant in cancer cells with stem-cell like properties. In the present study, we showed that two Pt-resistant human cancer cell lines exhibited stem-cell like EMT properties, had high cellular GSH and accumulated significantly less cellular Pt compared to their parental cells, and failed to undergo apoptosis when exposed to Pt at the drug concentrations toxic to the parental cells. Importantly, we found that the natural compound β-phenylethyl isothiocyanate (PEITC) was able to effectively abolish this drug resistant mechanism by effective depletion of cellular GSH, leading to a significant increase in cellular Pt as well as DNA-bound Pt. A combination of PEITC and Pt showed a striking synergistic anticancer activity both in vitro and in vivo, as evidenced by an increase in drug-induced apoptosis, a loss of colony formation capacity, and significant suppression of tumor growth in mice. Taken together, our study shows a promising therapeutic strategy to overcome drug resistance to platinum-based chemotherapy and may potentially have broad implications in clinical treatment of cancer.
    No preview · Article · Dec 2012 · Biochemical pharmacology
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A 36-year-old woman had presented with dry cough for 2 months. Thoracic computed tomography (CT) scan showed a 12 cm × 8 cm ×5 cm mass in the anterior mediastinum. Due to intimately involving the aortic arch, tumor was removed incompletely. Residual tumor remained approximate 2 cm × 3 cm × 4 cm. Histologic diagnosis was a mature cystic teratoma containing a carcinoid. Subsequently, radiotherapy (RT) was administrated on residual tumor for a total dose of 50 Gy at 2 Gy/d fraction in 25 fractions. At 2-year follow-up, the patient had stable disease. In conclusion, adjuvant radiotherapy with 50 Gy is an effective approach for residual tumor of mediastinal carcinoid teratoma.
    Full-text · Article · Apr 2013 · Journal of Thoracic Disease
Show more